Effect of Non-alcoholic Beer in Cirrhosis (LFN-NAB)
Primary Purpose
Endothelial Dysfunction, Nutritional Status, Quality of Life
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Non-alcoholic beer
control
Sponsored by

About this trial
This is an interventional treatment trial for Endothelial Dysfunction focused on measuring cirrhosis, nutrition, sarcopenia, non-alcoholic beer
Eligibility Criteria
Inclusion Criteria:
- Liver Cirrhosis of any aetiology (liver biopsy or a combination of clinical and biochemical variables plus evidence of portal hypertension); without decompensation during the past month; serum creatinine <1.5 mg%; able to attend the appointed visits and willing to participate in the study.
Exclusion Criteria:
- Severe concomitant cardiopulmonary diseases; decompensated type 2 Diabetes Mellitus, insulin use or proliferative diabetic retinopathy; orthopedic or osteomuscular limitations; any type of cancer; primary sclerosing cholangitis and inflammatory bowel disease.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Control
Non-alcoholic Beer
Arm Description
personalized nutritional therapy + aerobic exercise
non-alcoholic beer + personalized nutritional therapy + aerobic exercise
Outcomes
Primary Outcome Measures
Nutritional status
improvement in impedance-derived phase angle (PhA)
Endothelial function
improvement in flow-mediated dilation (brachial artery)
Endothelial dysfunction
improvement in serum markers of endothelial function (v.gr. nitric oxide, NO; prostacyclin, PGI2, etc.)
Quality of life questionnaire
Improvement in quality of life questionnaire CLDQ (chronic liver disease questionnaire)
Changes in the heterogeneity of gut Microbiota
Changes in the heterogeneity of fecal microbiota in terms of bacterial diversity will be assessed
Secondary Outcome Measures
Full Information
NCT ID
NCT04041115
First Posted
April 26, 2019
Last Updated
August 31, 2022
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
1. Study Identification
Unique Protocol Identification Number
NCT04041115
Brief Title
Effect of Non-alcoholic Beer in Cirrhosis
Acronym
LFN-NAB
Official Title
Effect of a Multifactorial Intervention (Non-alcoholic Beer, Diet and Exercise) on Endothelial Function, Nutritional Status and Quality of Life in Patients With Cirrhosis
Study Type
Interventional
2. Study Status
Record Verification Date
March 2019
Overall Recruitment Status
Completed
Study Start Date
January 2016 (Actual)
Primary Completion Date
December 2018 (Actual)
Study Completion Date
August 15, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The implementation of nutritional strategies targeting several variables at once could benefit patients with cirrhosis. Non-alcoholic beer has different compounds derived from hops that exert antioxidant, anti-inflammatory and nutritional properties. The aim of this study is to evaluate the effect of diet + exercise and non-alcoholic beer on nutritional status, endothelial function and quality of life in patients with cirrhosis.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Endothelial Dysfunction, Nutritional Status, Quality of Life
Keywords
cirrhosis, nutrition, sarcopenia, non-alcoholic beer
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
42 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Control
Arm Type
Active Comparator
Arm Description
personalized nutritional therapy + aerobic exercise
Arm Title
Non-alcoholic Beer
Arm Type
Active Comparator
Arm Description
non-alcoholic beer + personalized nutritional therapy + aerobic exercise
Intervention Type
Dietary Supplement
Intervention Name(s)
Non-alcoholic beer
Intervention Description
Treatment consisted of 330ml non-alcoholic beer per day, plus an individualized dietary program and an exercise program with a pedometer-based bracelet to reach at least 5000 steps/day during 2 + 8 weeks.
Intervention Type
Other
Intervention Name(s)
control
Intervention Description
Treatment consisted of 330ml of water, plus an individualized dietary program and an exercise program with a pedometer-based bracelet to reach at least 5000 steps/day during 2 + 8 weeks.
Primary Outcome Measure Information:
Title
Nutritional status
Description
improvement in impedance-derived phase angle (PhA)
Time Frame
8 weeks
Title
Endothelial function
Description
improvement in flow-mediated dilation (brachial artery)
Time Frame
8 weeks
Title
Endothelial dysfunction
Description
improvement in serum markers of endothelial function (v.gr. nitric oxide, NO; prostacyclin, PGI2, etc.)
Time Frame
8 weeks
Title
Quality of life questionnaire
Description
Improvement in quality of life questionnaire CLDQ (chronic liver disease questionnaire)
Time Frame
8 weeks
Title
Changes in the heterogeneity of gut Microbiota
Description
Changes in the heterogeneity of fecal microbiota in terms of bacterial diversity will be assessed
Time Frame
8 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Liver Cirrhosis of any aetiology (liver biopsy or a combination of clinical and biochemical variables plus evidence of portal hypertension); without decompensation during the past month; serum creatinine <1.5 mg%; able to attend the appointed visits and willing to participate in the study.
Exclusion Criteria:
Severe concomitant cardiopulmonary diseases; decompensated type 2 Diabetes Mellitus, insulin use or proliferative diabetic retinopathy; orthopedic or osteomuscular limitations; any type of cancer; primary sclerosing cholangitis and inflammatory bowel disease.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ricardo U. Macías-Rodríguez, M.D., Ph.D.
Organizational Affiliation
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Official's Role
Study Director
12. IPD Sharing Statement
Learn more about this trial
Effect of Non-alcoholic Beer in Cirrhosis
We'll reach out to this number within 24 hrs